首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   946篇
  免费   79篇
  国内免费   2篇
耳鼻咽喉   12篇
儿科学   48篇
妇产科学   23篇
基础医学   143篇
口腔科学   63篇
临床医学   97篇
内科学   144篇
皮肤病学   7篇
神经病学   156篇
特种医学   15篇
外科学   66篇
综合类   3篇
预防医学   139篇
眼科学   11篇
药学   63篇
肿瘤学   37篇
  2024年   1篇
  2023年   8篇
  2022年   13篇
  2021年   15篇
  2020年   21篇
  2019年   23篇
  2018年   31篇
  2017年   23篇
  2016年   30篇
  2015年   34篇
  2014年   38篇
  2013年   41篇
  2012年   89篇
  2011年   81篇
  2010年   47篇
  2009年   40篇
  2008年   77篇
  2007年   71篇
  2006年   53篇
  2005年   62篇
  2004年   60篇
  2003年   62篇
  2002年   42篇
  2001年   7篇
  2000年   7篇
  1999年   6篇
  1998年   6篇
  1997年   7篇
  1996年   6篇
  1995年   5篇
  1994年   5篇
  1993年   4篇
  1992年   5篇
  1990年   1篇
  1989年   1篇
  1987年   1篇
  1984年   1篇
  1982年   1篇
  1981年   1篇
  1979年   1篇
排序方式: 共有1027条查询结果,搜索用时 140 毫秒
11.
12.
13.
14.
15.
BACKGROUND: The aim was to assess which factors cause a systematic error in serum total cholesterol measurements and how bias can influence the interpretation of serum cholesterol changes of the Finnish population. METHODS: Data on precision and accuracy during 27 years for serum total cholesterol were documented from participation in 438 rounds of five different external quality assessment (EQA) programs. RESULTS: The mean annual accuracy (bias) of the cholesterol assay using the results from all EQAs during 1978-2004 was -0.74% (95%CI -0.88 to -0.60). An exceptionally large deviation in bias coincided with the introduction of a new serum calibrator lot. New methods or instrumentation had only a minor impact on serum cholesterol bias. The mean serum cholesterol bias during the latest five population studies in 1982-2002 was -0.10% (95%CI -0.60 to 0.40) but comparison of the bias between the last study (CDC EQA in 2002) and the four previous ones (WHO EQA) showed a net difference of 3.32% (p<0.001). Correcting the mean serum cholesterol of men with respect to WHO and CDC EQA bias changed the interpretation for the last two survey years from an increase of 1.8% to no change. CONCLUSIONS: It is necessary to participate in EQA programs, which include target values measured by the CDC cholesterol reference method and then to perform bias corrections on the mean cholesterol values of the populations.  相似文献   
16.
BACKGROUND: Copayments are common measures intended to control drug expenditures and promote rational prescribing. In Finland, new antiglaucoma drugs start with a high copayment, but once sufficient clinical experience is available, they are reevaluated and can receive a lower copayment status. OBJECTIVE: This study assessed the effect of changes in copayment level on the adoption of 2 antiglaucoma drugs. METHODS: A retrospective analysis was performed from 1997 to 2001 using the Finnish national register of reimbursed drug purchases, which covers approximately 98% of all antiglaucoma drug purchases in the country. There were 172,293 purchases of dorzolamide (plain or combined with timolol) and 281,377 purchases of latanoprost. An interrupted time-series design from approximately 30 months before and 20 months after the change in copayment was used in the analysis. The main outcome measures were the numbers of defined daily doses (DDDs) purchased and the monthly numbers of patients who purchased the study drugs for the first time before and after the change in copayment. RESULTS: A substantial increase in consumption of both dorzolamide and latanoprost was seen immediately after the introduction of the lower copayment. The monthly consumption of dorzolamide was 60,713 DDDs higher and the monthly consumption of latanoprost was 49,330 DDDs higher than expected according to the utilization trend during the higher copayment period. Twelve months later, the observed consumption of dorzolamide was 109% higher and that of latanoprost was 21% higher than if the copayment had remained the same. The number of new patients using the study drugs peaked within 2 months of the lower copayment, but the amount consumed per patient per day remained quite stable. CONCLUSIONS: Decreasing the copayment of a new antiglaucoma drug to the same level as the copayments of alternative drugs accelerated the adoption of these new products in Finland.  相似文献   
17.
Full‐information factor analysis of ordinal data was employed to determine the factorial structure of the responses of 31,822 adult Swedish women to the 20 “positive” psychotic experience items of the Community Assessment of Psychic Experiences (CAPE) questionnaire. Five separable but correlated trait dimensions were found, reflecting Paranoia, Grandiosity, Magical Thinking, Delusions, and Hallucinations. High scores on any dimension were associated with a higher probability of questionnaire‐assessed lifetime major depressive episodes or generalized anxiety disorder, though Grandiosity was so only to a very small degree. Our results closely match previous findings among adolescents and young women, and demonstrate that psychotic experiences cannot be considered a single trait. Copyright © 2013 John Wiley & Sons, Ltd.  相似文献   
18.
19.
Archives of Women's Mental Health - To assess psychosocial and somatic risk factors related to pregnancy, and pregnancy-related complications or disorders in women with schizophrenia compared...  相似文献   
20.
Myocardial infarction (MI), commonly known as a heart attack, is the irreversible necrosis of heart muscle secondary to prolonged ischemia, which is an increasing problem in terms of morbidity, mortality and healthcare costs worldwide. Along with the idea to develop nanocarriers that efficiently deliver therapeutic agents to target the heart, in this study, we aimed to test the in vivo biocompatibility of different sizes of thermally hydrocarbonized porous silicon (THCPSi) microparticles and thermally oxidized porous silicon (TOPSi) micro and nanoparticles in the heart tissue. Despite the absence or low cytotoxicity, both particle types showed good in vivo biocompatibility, with no influence on hematological parameters and no considerable changes in cardiac function before and after MI. The local injection of THCPSi microparticles into the myocardium led to significant higher activation of inflammatory cytokine and fibrosis promoting genes compared to TOPSi micro and nanoparticles; however, both particles showed no significant effect on myocardial fibrosis at one week post-injection. Our results suggest that THCPSi and TOPSi micro and nanoparticles could be applied for cardiac delivery of therapeutic agents in the future, and the PSi biomaterials might serve as a promising platform for the specific treatment of heart diseases.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号